Medullary thyroid carcinoma is a relatively rare thyroid cancer accounting for about 5% to 10% of all thyroid cancers.
Medical Surveillance Accounts for Excess Thyroid Cancers in Post-9/11 Firefighters
Increased rates of thyroid cancer among World Trade Center (WTC)-exposed firefighters and emergency medical service personnel who participated in rescue/recovery efforts after 9/11 are likely due to medical surveillance rather than an actual increase in disease. This is the conclusion of a recently published study in JAMA Internal Medicine (https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2764101) in which investigators found excess […]
Letter: Association Between Incretin Mimetics and Medullary Thyroid Cancer
Otolaryngologist patients with medullary thyroid cancer should not be taking GLP-1 medications at this time due to the risk.
Changes in the Management of Thyroid Cancer
An expert panel reviewed the main changes to thryoid cancer management from molecular testing to surveillance in select cases, and from nerve monitoring to the choice between total thyroidectomy over hemi-thyroidectomy for certain tumors.
Does Mutational Analysis Influence the Management of Differentiated Thyroid Cancers?
It is evident that BRAF does predict recurrence and unfavorable characteristics in differentiated thyroid cancers (DTC).
Interplay of Factors Account for Rise in Thyroid Cancer Diagnoses
Most of the increase in incidence of thyroid cancer is related to factors that promote early diagnosis of low-risk lesions.
Changes in Thyroid Cancer Incidence Post-2009 ATA Guidelines
The rapid increase in thyroid cancer incidence rates over the past three decades has recently slowed
Research Highlights from the 2017 TRIO Annual Meeting
Investigators from around the country presented their findings at the 120th Annual Meeting of the Triological Society
New Research Calls for Sex-Specific Therapies for Thyroid, Head and Neck Cancer
Study Raises Concern over Imaging after Thyroid Cancer
The use of neck ultrasounds, radioiodine scans, and PET scans in people diagnosed with thyroid cancer was associated with additional treatment for recurrence.